Luis Pizarro, Unitaid’s newly-appointed Executive Director comes to the organization with sizeable depth and breadth of experience – as the leader of Geneva’s Drugs for Neglected Diseases Initiative (DNDi) and before that, leadership of ventures in Africa, Asia and the Americas. However, his main challenge at Unitaid will be steadying the financially troubled organization, which […] Continue reading ->
The Pandemic Agreement talks resumed at the World Health Organization’s (WHO) headquarters on Monday, kicking off with a public “debriefing” summarising the incremental progress made during informal talks conducted over May and June, followed by a closed session on existing models for sharing data on pathogens with pandemic potential. Speaking at the opening of the […] Continue reading ->
The dramatic global health budget cutbacks in services for maternal and reproductive health and sexually transmitted infections (STIs) have produced 17 million unintended pregnancies, and more than 34,000 preventable maternal deaths in just the first year since cuts were made.  That recent assessment by French and Washington DC-based analyses, was cited by Guyana’s UN Ambassador […] Continue reading ->
  As the Global Fund to Fight AIDS, Tuberculosis and Malaria heads into a secretive but highly contentious election of a new Executive Director, the names of several candidates reported to be on the shortlist, all US citizens, have surfaced. They include former Global Fund Executive Director Mark Dybul, former Trump appointee William Steiger and […] Continue reading ->
A stiffly-worded resolution approved this week by World Health Organization member states condemned the “wanton” destruction of Gaza’s health facilities and “extreme violence of the illegal Israeli settlers.” The decision called on Israel to ensure humanitarian access to Gaza of medicines, fuel, and other essentials, refrain from further destruction of food production and water supplies,  […] Continue reading ->
On the five-year anniversary of the Global Diabetes Compact, WHO has issued a call to manufacturers to submit requests for “prequalification” of generic versions of the GLP-1 drug semaglutide for diabetes management – the drug that initially became famous for weight-loss – as well as fast-acting insulin analogues that have gained popularity over human insulin […] Continue reading ->